Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Corpechot

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosisChristophe Corpechot, Armelle Poujol-Robert, Dominique Wendum, et al.
Hepatology (Baltimore, Md.)|August 30, 2008
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosisChristophe Corpechot, Ludovico Abenavoli, Nabila Rabahi, et al.
Hepatology (Baltimore, Md.)|October 1, 2016
Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitisGéraldine Dahlqvist, Farid Gaouar, Fabrice Carrat, et al.
Hepatology (Baltimore, Md.)|March 28, 2013
Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patientsRaoul Poupon, Olivier Rosmorduc, Pierre Yves Boëlle, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2024
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statementAldo J Montano-Loza, Christophe Corpechot, Patrizia Burra, et al.
Gastroenterology|January 7, 2014
Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitisChristophe Corpechot, Farid Gaouar, Ahmed El Naggar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2023
Focus on Liver Function Abnormalities in Patients With Turner Syndrome: Risk Factors and Evaluation of Fibrosis RiskNathalie Bourcigaux, Emma Dubost, Jean-Claude Buzzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing CholangitisFranziska Jung, Nora Cazzagon, Eik Vettorazzi, et al.
European Radiology|March 21, 2024
Spontaneous perforation of the common bile duct: an uncommon complication of primary sclerosing cholangitisLucas Dargent, Sara Lemoinne, Karine Louvion, et al.
Clinics and Research in Hepatology and Gastroenterology|February 18, 2019
Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitisNora Cazzagon, Olivier Chazouillères, Christophe Corpechot, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosisChristophe Corpechot, Armelle Poujol-Robert, Dominique Wendum, et al.
Hepatology (Baltimore, Md.)|August 30, 2008
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosisChristophe Corpechot, Ludovico Abenavoli, Nabila Rabahi, et al.
Hepatology (Baltimore, Md.)|October 1, 2016
Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitisGéraldine Dahlqvist, Farid Gaouar, Fabrice Carrat, et al.
Hepatology (Baltimore, Md.)|March 28, 2013
Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patientsRaoul Poupon, Olivier Rosmorduc, Pierre Yves Boëlle, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2024
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statementAldo J Montano-Loza, Christophe Corpechot, Patrizia Burra, et al.
Gastroenterology|January 7, 2014
Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitisChristophe Corpechot, Farid Gaouar, Ahmed El Naggar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2023
Focus on Liver Function Abnormalities in Patients With Turner Syndrome: Risk Factors and Evaluation of Fibrosis RiskNathalie Bourcigaux, Emma Dubost, Jean-Claude Buzzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing CholangitisFranziska Jung, Nora Cazzagon, Eik Vettorazzi, et al.
European Radiology|March 21, 2024
Spontaneous perforation of the common bile duct: an uncommon complication of primary sclerosing cholangitisLucas Dargent, Sara Lemoinne, Karine Louvion, et al.
Clinics and Research in Hepatology and Gastroenterology|February 18, 2019
Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitisNora Cazzagon, Olivier Chazouillères, Christophe Corpechot, et al.
Pageof 12